(MENAFN- IMARC Group)
According to IMARC Group latest report titled“ Immunodiagnostics Market: Global industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032 ”, offers a comprehensive analysis of the industry, which comprises insights on
immunodiagnostic market
analysis . The report also includes competitor and regional analysis, and contemporary advancements in the global market.
The global immunodiagnostics market size reached US$ 18.8 Billion in 2023. Looking forward, IMARC Group expects the
market to reach US$ 34.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032.
Immunodiagnostics are tests utilized in the medical field to diagnose diseases by detecting specific biomarkers in a patient's sample, usually blood or tissue. These tests are characterized by their specificity and sensitivity to particular antigens or antibodies. The working mechanism involves the use of immunological reactions, such as antigen-antibody binding, which are then quantified and analyzed. Properties of these diagnostic tools include rapid response time, high accuracy, and the ability to be automated for large-scale screenings. Advantages include facilitating early disease detection, monitoring disease progression, and aiding in the selection of appropriate therapeutic strategies.
Request to Get the Sample Report:
https://www.imarcgroup.com/immunodiagnostics-market/requestsample
Market Trends:
The global market is majorly driven by the increasing prevalence of chronic and infectious diseases, necessitating advanced diagnostic solutions. The healthcare industry's shift towards personalized medicine is also influencing demand, as immunodiagnostics play a crucial role in tailoring treatments. Concurrently, advancements in biotechnology are enabling the development of more sophisticated diagnostic platforms. Additionally, the aging population, which is more susceptible to diseases, is a critical factor increasing the utilization of these tests. The market is further supported by government initiatives promoting preventive healthcare measures. Increased investment in healthcare infrastructure, particularly in diagnostic laboratories, continues to propel the market forward. Furthermore, the rise in health awareness and a focus on wellness contribute to the growing adoption of immunodiagnostics. The integration of IT in healthcare, leading to the emergence of telehealth and remote diagnostics, is also a significant trend bolstering the market.
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories Arkray Inc. bioMérieux SA Bio-Rad Laboratories Inc. DiaSorin S.p.A. Hoffmann-La Roche AG Immunodiagnostic Systems Holdings PLC Johnson & Johnson Siemens AG Sysmex Corporation Thermo Fisher Scientific Inc
Immunodiagnostics Market Segmentation:
Our report has categorized the market based on region, product, technology, application and end use industry.
Breakup by Product:
Reagents Instruments Software and Services
Breakup by Technology:
Enzyme-Linked Immunosorbent Assay Chemiluminescence Immunoassay Fluorescent Immunoassay Radioimmunoassay Rapid Test Others
Breakup by Application:
Infectious Diseases Oncology and Endocrinology Hepatitis and Retrovirus Bone and Mineral Autoimmunity Cardiac Biomarker Others
Breakup by End User:
Hospitals Clinical Laboratories Academic and Research Centers Pharmaceutical and Biotechnology Industry Others
Breakup by Region:
North America (United States, Canada) Europe (Germany, France, United Kingdom, Italy, Spain, Others) Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others) Latin America (Brazil, Mexico, Others) Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
Market Performance (2018-2023) Market Outlook (2024-2032) Porter's Five Forces Analysis Market Drivers and Success Factors SWOT Analysis Value Chain Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email:
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
MENAFN25022024004122016232ID1107895240
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.